Article thumbnail

AAV-mediated delivery of optogenetic constructs to the macaque brain triggers humoral immune responses

By Skyler D. Mendoza, Yasmine El-Shamayleh and Gregory D. Horwitz

Abstract

Gene delivery to the primate central nervous system via recombinant adeno-associated viral vectors (AAV) allows neurophysiologists to control and observe neural activity precisely. A current limitation of this approach is variability in vector transduction efficiency. Low levels of transduction can foil experimental manipulations, prompting vector readministration. The ability to make multiple vector injections into the same animal, even in cases where successful vector transduction has already been achieved, is also desirable. However, vector readministration has consequences for humoral immunity and gene delivery that depend on vector dosage and route of administration in complex ways. As part of optogenetic experiments in rhesus monkeys, we analyzed blood sera collected before and after AAV injections into the brain and quantified neutralizing antibodies to AAV using an in vitro assay. We found that injections of AAV1 and AAV9 vectors elevated neutralizing antibody titers consistently. These immune responses were specific to the serotype injected and were long lasting. These results demonstrate that optogenetic manipulations in monkeys trigger immune responses to AAV capsids, suggesting that vector readministration may have a higher likelihood of success by avoiding serotypes injected previously

Publisher: 'American Physiological Society'
Year: 2017
DOI identifier: 10.1152/jn.00780.2016
OAI identifier: oai:authors.library.caltech.edu:74465
Provided by: Caltech Authors

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles